[1] 叶宸.miR-145在宫颈癌放射敏感性调节中的作用及机制研究[D].上海:第二军医大学,2014. Ye C.Investigation of the effect and mechanism of miR-145 on regulating the radiosensitivity of cervical cancer[D].Shanghai:The Second Military Medical University,2014. [2] 张鸿博.miR-145对宫颈癌Hela细胞的增殖、凋亡及其对紫杉醇药物敏感性的研究[D].长春:吉林大学,2014. Zhang HB.miR-145 influence on the proliferation and apoptosis of Hela cervical carcinoma cells and its drug sensitivity of paclitaxel[D].Changchun:Jilin University,2014. [3] Zhang B,Chen J,Ren ZH,et al. A specific miRNA signature promotes radioresistance of human cervical cancer cells[J].Cancer Cell Int,2013,13:118.DOI:10.1186/1475-2867-13-118. [4] 李连香,陈丽宏.宫颈癌新辅助化疗miRNA的差异表达[J].现代中西医结合杂志,2014,23(2):122-124,129.DOI:10.3969/j.issn.1008-8849.2014.02.004. Li LX,Chen LH.Differential expression of miRNA in neoadjuvant chemotherapy for cervical cancer[J].Mod J Integr Trad Chin Western Med,2014,23(2):122-124,129.DOI:10.3969/j.issn.1008-8849.2014.02.004. [5] Chen B,Hou ZH,Li CD,et al. MiRNA-494 inhibits metastasis of cervical cancer through Pttg1[J].Tumor Biol,2015,36(9):7143-7149.DOI:10.1007/s13277-015-3440-0. [6] Trang P,Medina PP,Wiggins JF,et al. Regression of murine lung tumors by the let-7 microRNA[J].Oncogene,2010,29(11):1580-1587.DOI:10.1038/onc.2009.445. [7] 何林蓉.浅论辅助性化疗对宫颈癌细胞miRNA表达差异的影响[J].当代医药论丛,2015,13(13):268-269. He LR.Effect of adjuvant chemotherapy on the expression of miRNA in cervical cancer cells[J].Contemp Med Forum,2015,13(13):268-269. [8] Chen Z,Zeng HZ,Guo Y,et al.miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc[J].J Exp Clin Cancer Res,2010,29:151.DOI:10.1186/1756-9966-29-151. [9] 邓凯贤,柳晓春,郑玉华,等.miR-143和miR-145在宫颈癌组织中的异常表达及临床意义[J].妇产与遗传(电子版),2014,4(4):12-17.DOI:10.3868/j.issn.2095-1558.2014.04.003. Deng KX,Liu XR,Zheng YH,et al. Abnormal expression of. MiR-143 and miR-145 in cervical carcinoma and its clinical significance[J].Obstet Gynecol Genet (Elec Ed),2014,4(4):12-17.DOI:10.3868/j.issn.2095-1558.2014.04.003. [10] 许常娟,邓丹玲,丁彦青,等.miRNA-143靶向MACC1抑制宫颈癌细胞侵袭[J].中国肿瘤临床,2015,42(18):900-905.DOI:10.3969/j.issn.1000-8179.2015.18.709. Xu CJ,Deng DL,Ding YQ,et al. Inhibitory effect of miRNA-143 on the invasiveness of cervical cancer cells by targeting MACC1[J].China J Clin Oncol,2015,42(18):900-905.DOI:10.3969/j.issn.1000-8179.2015.18.709. [11] 吴阳.放疗联合不同剂量顺铂周疗方案治疗中晚期宫颈癌的疗效[J].中国老年学杂志,2015,(20):5815-5816.DOI:10.3969/j.issn.1005-9202.2015.20.063. Wu Y,Radiotherapy combined with different doses of cisplatin regimen in the treatment of advanced cervical cancer[J].Chin J Gerontol,2015,(20):5815-5816.DOI:10.3969/j.issn.1005-9202.2015.20.063. [12] 杨镇鸣,刘鸣.miRNA-145与肿瘤的相关性研究进展[J].标记免疫分析与临床,2015,22(11):1173-1175.DOI:10.11748/bjmy.issn.1006-1703.2015.11.027. Yang ZM,Liu M.Research progress of the relativity of miRNA-145 and tumor[J].Lab Immun Clin Med,2015,22(11):1173-1175.DOI:10.11748/bjmy.issn.1006-1703.2015.11.027. [14] 张静,霍满鹏,慕明涛,等.miR-145在转染的HeLa细胞中的表达及其对CDK6 的靶向抑制[J].细胞与分子免疫学杂志,2014,30(3):274-277. Zhang J,Huo MP,Mu MT,et al. Expression of miR-145 in transfected HeLa cells and its effect on the targeted inhibition of CDK6[J].Chin Journal Cell Mol Immunol,2014,30(3):274-277. [15] Cioce M,Ganci F,Canu V,et al. Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma[J].Oncogene,2014,33(46):5319-5331.DOI:10.1038/onc.2013.476. |
|
|